Comment on: Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placebo

Editorial commentary on “Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo”

Translational Andrology and Urology ◽

10.21037/tau-2020-02 ◽

2020 ◽

Vol 9 (3) ◽

pp. 1009-1012

Author(s):

Tomonori Yamanishi ◽

Tomohiko Kamasasko ◽

Kanya Kaga ◽

Miki Fuse

Keyword(s):

Clinical Trial ◽

Overactive Bladder ◽

Safety And Efficacy ◽

Clinical Trial Database ◽

Editorial Commentary

Re: Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

The Journal of Urology ◽

10.1097/ju.0000000000001286 ◽

2020 ◽

Vol 204 (6) ◽

pp. 1385-1386

Author(s):

Alan J. Wein

Keyword(s):

Clinical Trial ◽

Overactive Bladder ◽

Safety And Efficacy ◽

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

European Urology ◽

10.1016/j.eururo.2019.09.024 ◽

2020 ◽

Vol 77 (1) ◽

pp. 119-128 ◽

Cited By ~ 10

Author(s):

Christopher R. Chapple ◽

Francisco Cruz ◽

Linda Cardozo ◽

David Staskin ◽

Sender Herschorn ◽

...

Keyword(s):

Clinical Trial ◽

Overactive Bladder ◽

Safety And Efficacy ◽

Phase I Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder

10.31525/ct1-nct04186442 ◽

2019 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Overactive Bladder ◽

Phase I ◽

Phase I Clinical Trial ◽

Safety And Efficacy

Safety and efficacy of a composition of purified and specific cytoplasm extracts of pollen (PSCEP), pumpkin seed extract and vitamin E (Femaxeen®) in women with overactive bladder symptoms. A randomized, double-blind, placebo-controlled clinical trial

Maturitas ◽

10.1016/j.maturitas.2019.04.153 ◽

2019 ◽

Vol 124 ◽

pp. 166-167

Author(s):

Santiago Palacios ◽

Marieta Ramirez ◽

Mariella Lilue ◽

Ph Diaz

Keyword(s):

Clinical Trial ◽

Vitamin E ◽

Overactive Bladder ◽

Seed Extract ◽

Controlled Clinical Trial ◽

Double Blind ◽

Pumpkin Seed ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Bladder Symptoms

How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies

Tzu Chi Medical Journal ◽

10.4103/tcmj.tcmj_167_20 ◽

2020 ◽

Vol 0 (0) ◽

pp. 0

Author(s):

Hann-Chorng Kuo

Keyword(s):

Clinical Trial ◽

Overactive Bladder ◽

Database Analysis ◽

Cardiovascular safety of mirabegron: analysis of an integrated clinical trial database of patients with overactive bladder syndrome

Journal of the American Society of Hypertension ◽

10.1016/j.jash.2018.08.001 ◽

2018 ◽

Vol 12 (11) ◽

pp. 768-778.e1 ◽

Cited By ~ 8

Author(s):

William B. White ◽

Emad Siddiqui ◽

Tri Tat ◽

Billy Franks ◽

Carol R. Schermer

Keyword(s):

Clinical Trial ◽

Overactive Bladder ◽

Overactive Bladder Syndrome ◽

Cardiovascular Safety ◽

A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain

10.31525/ct1-nct04014478 ◽

2019 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Cancer Pain ◽

Safety And Efficacy

A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome.

10.31525/ct1-nct04111341 ◽

2019 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Chinese Medicine ◽

Traditional Chinese Medicine ◽

Sjögren’S Syndrome ◽

Sjögren's Syndrome ◽

Sjogren’S Syndrome ◽

Sjogren's Syndrome ◽

Safety And Efficacy ◽

Sjögren‘S Syndrome

Clinical Trial Evaluating the Safety and Efficacy of the Use of Chitosan Gel in Patients With Chronic Wounds

10.31525/ct1-nct04178525 ◽

2019 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Chronic Wounds ◽

Safety And Efficacy ◽

Chitosan Gel